Direct-To-Consumer (DTC) Genetic Testing Market Analysis & Forecast to 2028 by Key Players, Share, Trend, Segmentation Global Market Insights recently added a detailed Direct-To-Consumer (DTC) Genetic Testing Market research study across the global, regional and country level. The report provides 360° analysis from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global market and estimates the future trend of the industry based on this detailed study. Browse key industry insights spread across 190 pages with 255 market data tables & 12 figures & charts from the report, “Direct-To-Consumer Genetic Testing Market Analysis By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomic Testing, Skincare Testing), Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) chips, Whole Genome Sequencing (WGS)), Distribution Channel (Online Platforms, Over-the-Counter), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents: https://www.gminsights.com/industry-analysis/direct-to-consumer-dtc-genetic-testingmarket Recently, technological advancements have created massive opportunities for product penetration. Moreover, increasing number of chronic diseases, along with the launch of personalized testing kits on online platforms, has also positively influenced the product landscape. Notably, industry players have been focusing on product innovation to gain a competitive edge in the direct-to-consumer genetic testing market, thereby fueling business growth. For instance, in January 2022, 23andMe, a major consumer genetics firm, received 510(k) clearance from the U.S. FDA for a test that detects a hereditary marker for prostate cancer. The test gives information on the presence of the G84E mutation in the user's HOXB13 gene, which has been shown to increase the risk of prostate cancer. Overall, the direct-to-consumer genetic testing market has been segregated in terms of test type, technology, distribution channel, and region. With reference to test type, the market has been classified into predictive testing, carrier testing, skincare testing, ancestry and relationship testing, and nutrigenomic testing. Among these, the nutrigenomic testing segment garnered a revenue of over USD 315 million in 2021 and is poised to exhibit sturdy growth over 2022-2028. The growth of this segment is mainly due to increasing awareness about health and wellness in people. On the basis of technology, the direct-to-consumer genetic testing market has been segmented into targeted analysis, whole genome sequencing (WGS), and single nucleotide © 2022 Global Market Insights Inc. All Rights Reserved
www.gminsights.com